Agenus (AGEN) Competitors

XOMA (NASDAQ:XOMA) and Agenus (NASDAQ:AGEN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Does the MarketBeat Community prefer XOMA or AGEN?

Agenus received 28 more outperform votes than XOMA when rated by MarketBeat users. Likewise, 69.19% of users gave Agenus an outperform vote while only 65.82% of users gave XOMA an outperform vote.

Company	Underperform	Outperform
XOMA	Outperform Votes 439 65.82%	Underperform Votes 228 34.18%
Agenus	Outperform Votes 467 69.19%	Underperform Votes 208 30.81%

Which has stronger valuation & earnings, XOMA or AGEN?

XOMA has higher earnings, but lower revenue than Agenus. XOMA is trading at a lower price-to-earnings ratio than Agenus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$9.71M	28.54	-$40.83M	-$3.48	-6.76
Agenus	$156.31M	0.50	-$245.76M	-$11.24	-0.30

Which has more volatility and risk, XOMA or AGEN?

XOMA has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Agenus has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500.

Do analysts prefer XOMA or AGEN?

XOMA presently has a consensus price target of $72.00, suggesting a potential upside of 206.12%. Agenus has a consensus price target of $10.00, suggesting a potential upside of 201.20%. Given XOMA's stronger consensus rating and higher probable upside, analysts plainly believe XOMA is more favorable than Agenus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
XOMA	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Agenus	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Is XOMA or AGEN more profitable?

Agenus has a net margin of -145.89% compared to XOMA's net margin of -151.34%. Agenus' return on equity of 0.00% beat XOMA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
XOMA	-151.34%	-24.95%	-9.64%
Agenus	-145.89%	N/A	-85.68%

Does the media refer more to XOMA or AGEN?

In the previous week, XOMA had 1 more articles in the media than Agenus. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Agenus. XOMA's average media sentiment score of 1.63 beat Agenus' score of 1.00 indicating that XOMA is being referred to more favorably in the media.

Company	Overall Sentiment
XOMA	Very Positive
Agenus	Positive

Do insiders and institutionals believe in XOMA or AGEN?

95.9% of XOMA shares are held by institutional investors. Comparatively, 61.5% of Agenus shares are held by institutional investors. 7.2% of XOMA shares are held by insiders. Comparatively, 4.6% of Agenus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

XOMA beats Agenus on 11 of the 18 factors compared between the two stocks.